An observational study in Sleep Apnea, Obstructive, sponsored by Technische Universität Dresden. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-20.
Sponsored by Technische Universität Dresden · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 68 studies in Sleep Apnea, Obstructive with a site in Germany — 7 open to participants now, 13 under way, 5 of them phase 3. Sleep Apnea, Obstructive · Germany.
Among the 68 studies in Sleep Apnea, Obstructive with a site in Germany, this one is the 7th largest by planned enrollment of the 13 observational ones that give a count, is one of 3 that started in 2024, is one of 13 observational ones, reaches primary completion later than 2 of the 12 other live ones, and was the 59th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →7 of the 68 studies in Sleep Apnea, Obstructive with a site in Germany are open now. Recruiting first, the newest first:
Novo Nordisk A/S · Sites in Germany, United States, Australia and 7 more countries
Ages 18+
Novo Nordisk A/S · Sites in Germany, United States, Australia and 7 more countries
Ages 18+
Eli Lilly and Company · Sites in Germany, United States, Australia and 8 more countries
Ages 18+
Inspire Medical Systems, Inc. · Sites in Germany, Austria, Belgium and 4 more countries
Ages 18+
Wissenschaftliches Institut Bethanien e.V · Sites in Germany, Belgium, France and 8 more countries
Ages 40+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
68 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 136 is above the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 80 across the 55 interventional studies, 136 across the 13 observational. Of the 48 that completed or were terminated, 14 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
51 of 68 have an industry lead sponsor. The 10 most frequent:
Technische Universität Dresden is the lead sponsor of 247 studies on the registry; 46 are open to participants now.
Technische Universität Dresden has 1 study filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
3 of the studies in Sleep Apnea, Obstructive with a site in Germany that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07225686Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy | 2027-08-20 |
| NCT07226765Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy | 2027-08-30 |
| NCT06970171University Medicine GreifswaldAcceptance of Mandibular Advancement Devices | 2027-05-05 |
Add all 3 to your calendar (.ics) → With an account.
Among the 68 studies in Sleep Apnea, Obstructive with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to investigate biomarkers and neurocognitive markers of neurodegenerative processes in obstructive sleep apnea patients.
The main questions the study aims to answer are:
Newly diagnosed patients with obstructive sleep apnea will be observed during the use of clinical prescribed positive pressure therapy. Different study related investigations take place before and six months after treatment start.
Researchers will compare after six months the group of adherent treatment participants with the non-adherent treatment participants group to investigate if differences in the observed neurobiological or neurocognitive parameters exist.
Patients that are reffered to the sleep lab of the University Hospital Dresden
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Concentration of neurofilament light chain
longitudinal analysis
Time frame: From enrollment to the follow up time point after 6 months of treatment
Concentration of Neurofilament light chain
in between the groups (assessed after 6 months)
Time frame: From enrollment to the follow up time point after 6 months of treatment, in between the groups
Concentration of Glial fibrillary acidic protein
longitudinal analysis and in between the groups (assessed after 6 months)
Time frame: From enrollment to the follow up time point after 6 months of treatment
Cognitive performance measured by SDMT, MoCA
Longitudinal analysis and in between the groups (assessed after 6 months)
Time frame: From enrollment to the follow up time point after 6 months of treatment
Objective sleep parameters measured by polysomnography or equivalent measuremt methods
Longitudinal analysis and in between the groups (assessed after 6 months). For example objective parameters like apnea-hypopnea-index per hour or sleep efficacy in %.
Time frame: From enrollment to the follow up time point after 6 months of treatment
Subjective sleep parameters measured by symptoms questionnaires (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index)
Longitudinal analysis and in between the groups (assessed after 6 months). For example parameters like sleepiness (ESS-questionnnaire, min to max 0 to 24 points) or sleep quality (PSQI-questionnaire, min to max 0 to 21 points). Lower score values represent fewer symptom load.
Time frame: From enrollment to the follow up time point after 6 months of treatment
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Dec 2025, 23 months after the start.
Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 23 months is below that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Technische Universität Dresden →